Cell Source, Inc. (33) | Uncategorized (8)
Recent Contracts
-
Amendment No. 2 to Sponsored Research Agreement dated October 18, 2021 between the University of Texas MD Anderson Cancer Center and Cell Source Ltd
(Filed With SEC on April 15, 2022)
-
Amendment No. 2 to Sponsored Research Agreement dated October 18, 2021 between The University of Texas M.D. Anderson Cancer Center and Cell Source Limited
(Filed With SEC on November 15, 2021)
-
(Filed With SEC on August 14, 2019)
-
(Filed With SEC on August 14, 2019)
-
(Filed With SEC on August 14, 2019)
-
AMENDMENT NO. 1 TO VETO CELL PRODUCTION AND CLINICAL TRIAL PROGRAM AGREEMENT
(Filed With SEC on May 20, 2019)
-
ยง 1 Subject matter
(Filed With SEC on April 1, 2019)
-
SPONSORED RESEARCH AGREEMENT
(Filed With SEC on April 1, 2019)